In clinical trials, treatment with MMF improved autoimmune cytopenias in patients with ALPS while inducing hypogammaglobulinemia in some; however, MMF had little to no effect on lymphoproliferation or elevated CD4−/CD8− DNTs (40, 41). Here, CD4 is linked to autoimmune lymphoproliferative syndrome.